Partnership advances liver cancer treatment
Scientist Live, 12 May 2025
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Scientist Live, 12 May 2025
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Outsourced Pharma, April 2023
Its lead single-use nasal dry powder device now available for commercial partnerships
Effective May 1st, 2020
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Speech during the Chinese Banquet at the Hyatt Hotel